SAFESKIN FIRST QUARTER SALES STRETCH 52% TO $17.5 MIL.; STERIS SYSTEM I AND STERIS 20 PRODUCTS HELP PUSH FISCAL YEAR 1994 SALES UP 71.9% TO $45.8 MIL.
This article was originally published in The Gray Sheet
Executive Summary
Hypoallergenic disposable latex glove firm Safeskin's first quarter 1994 sales sailed ahead 52% to $17.5 mil., pushing earnings up 22.6% to $2.8 mil. The growth stemmed from "strong market demand resulting from safety concerns about the spread of infectious disease, a continued shift in the market place towards powder-free gloves," and "pricing stability" for "premium-quality gloves," the firm said.